Quick Answer
PRECISION BIOSCIENCES INC reported Research And Development Expense of $54.17 million for the year ending 2025.
- PRECISION BIOSCIENCES INC showed a decrease of -9.0% in Research And Development Expense from 2024 to 2025.
- This data is from PRECISION BIOSCIENCES INC's annual report (Form 10-K), filed with the SEC on March 12, 2026.
- XBRL data for this metric is available from 2018 to 2025 (8 years of filings). Earlier data may not exist in machine-readable XBRL format as companies adopted electronic filing at different times.
- Quarterly values from 10-Q filings: Q1 2018: $8.12 million | Q2 2018: $10.87 million | Q3 2018: $9.74 million | Q1 2019: $19.96 million | Q2 2019: $22.76 million | Q3 2019: $19.79 million | Q1 2020: $24.88 million | Q2 2020: $25.18 million | Q3 2020: $24.87 million | Q1 2021: $25.59 million | Q2 2021: $37.24 million | Q3 2021: $25.94 million | Q1 2022: $19.97 million | Q2 2022: $22.94 million | Q3 2022: $11.76 million | Q1 2023: $11.05 million | Q2 2023: $13.09 million | Q3 2023: $15.85 million | Q1 2024: $13.34 million | Q2 2024: $17.23 million | Q3 2024: $13.08 million | Q1 2025: $13.59 million | Q2 2025: $12.77 million | Q3 2025: $13.35 million.
- Over the full 8 years of available data (2018 to 2025), PRECISION BIOSCIENCES INC's Research And Development Expense has grown by 20.1%.
- Historical annual values: Fiscal year 2025: $54.17 million | Fiscal year 2024: $59.56 million | Fiscal year 2023: $53.38 million | Fiscal year 2022: $46.12 million | Fiscal year 2021: $115.24 million | Fiscal year 2020: $98.06 million | Fiscal year 2019: $82.42 million | Fiscal year 2018: $45.12 million.
- Data sourced from SEC EDGAR public filings as of August 4, 2026.
Last verified: